Elevra Lithium stock
ELVRNASDAQElevra Lithium Limited, Basic MaterialsISIN US8057001013
38Score 38 out of 100, Weak
Price and trend
42 / 100
Price history
−14% in one yearThe chart shows daily closes over 1 year, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 57% below it.
Since September 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Normal: the price is neither overheated nor sold off (RSI 54).
The price is 75% below its 52-week high. Largest decline in 1 year: 79% (June 2026 to October 2026).
Chart figures for advanced users
- SMA 50$35.34
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$58.64
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)54
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$21.96
- The lowest closing price of the last twelve months.
- Resistance$102.33
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Elevra Lithium Limited belongs to the Other Precious Metals industry (Australia) and, with a market value of $486.22M, is number 24 of 29 companies in its industry on MEQIRI.
- This is an American depositary receipt (ADR).
- MEQIRI Score 38 out of 100 (Weak): rank 409 of 467 in Basic Materials, median 58.
Show more
- The P/E is 13.2 (Other Precious Metals median 16.1, own median of recent years 2.5).
- Our model puts fair value at $30.68, with the price 9% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- High marginNet margin 32.5% over the last 12 months, Other Precious Metals median 10.1%.Profitability 52
- More cash than debtCash $252.76M, financial debt $77.31M.Stability 53
Weaknesses
- DilutionShare count up 244% since 2021.Capital allocation 18
- Earnings per share fallingDown 25.6% a year since 2021.Growth 34
- Volatile share priceVolatility 85% a year over the last 12 months.Stability 53
The score is held back by fundamentals and capital allocation.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Fundamental quality fluctuates.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansValuation
Valuation signal
Fairly valuedClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $20.46 and expensive above $61.37 (uncertainty very high, based on the price swings of the past year).
Valuation metrics
From earnings times the industry P/E (16.1) alone; there are no viable cash flows for the cash-flow model.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In fiscal 2025, revenue fell 7.2% on the prior year. Revenue turned from negative at the start of the period to positive ($142.15M in the latest year).
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross −38%, operating −35%, net 30%.
Debt & balance sheet
latest quarterDebt is low, but interest coverage is weak. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- No date announced.
- Last reported
- 31 Aug 2026
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- 0.070.0%
- Revenue
- $268.31M−28.1%
- Earnings per share
- 0
- Revenue
- $313.58M−11.4%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook confirmed
Share price after the results: −5.4%First fiscal 2027 guidance: spodumene concentrate production of 198,000 to 210,000 tonnes, sales of 200,000 to 230,000 tonnes and capital expenditure of $120 million to $140 million.
“As we look to FY '27, we expect spodumene concentrate production of between 198,000 and 210,000 tonnes at a 5.2% growth. Concentrate sales are expected to be between 200,000 and 230,000 tonnes with a modest weighting towards the first half of the year based on inventory on hand at the end of June 2026.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 27 Aug 2026 (fiscal Q4 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
No open-market purchases or sales in the last 6 months.
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Elevra Lithium
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
467 rated companies in Basic Materials
- This company
- 38
- Sector median
- 58
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Other Precious Metals
The next larger and next smaller companies by market value
- McEwen MiningMUX $782.95M38
- Avino Silver & Gold MinesASM $779.63M61
- Metalla Royalty & StreamingMTA $720.85M40
- Santacruz Silver MiningSCZM $684.41M59
- IperionXIPX $534.28M33
- REalloysALOY $463.28M30
- Integra ResourcesITRG $426.03M50
- Lifezone MetalsLZM $403.72M33
ETFs that hold Elevra Lithium
Held by 1 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| L&G Battery Value-Chain UCITS ETFBATE | 0.49% | 0.49% | €668.78M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 30 Jun 2026
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 11 Nov 2026 ($1 = A$1.4579)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 28 Aug 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.